HRT Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-9,004
Closed -$1.15M – 3391
2025
Q1
$1.15M Buy
+9,004
New +$1.39M 0.01% 1066
2024
Q2
– Sell
-1,130
Closed -$207K – 2949
2024
Q1
$207K Sell
1,130
-600
-35% -$114K ﹤0.01% 1758
2023
Q4
$311K Buy
+1,730
New +$269K ﹤0.01% 1611
2023
Q3
– Sell
-1,492
Closed -$211K – 2978
2023
Q2
$211K Sell
1,492
-3,273
-69% -$525K ﹤0.01% 1816
2023
Q1
$802K Buy
+4,765
New +$850K 0.01% 1065
2022
Q4
– Sell
-18,144
Closed -$3.39M – 3013
2022
Q3
$3.39M Buy
+18,144
New +$3.83M 0.04% 409
2022
Q1
– Sell
-55,538
Closed -$14.7M – 3732
2021
Q4
$14.7M Sell
55,538
-7,594
-12% -$2.05M 0.08% 116
2021
Q3
$18.2M Buy
+63,132
New +$16.2M 0.11% 90
2020
Q3
– Sell
-43,292
Closed -$5.35M – 2268
2020
Q2
$5.35M Buy
+43,292
New +$5.09M 0.16% 112
2020
Q1
– Sell
-29,989
Closed -$2.77M – 1253
2019
Q4
$2.77M Buy
29,989
+25,876
+629% +$2.17M 0.12% 142
2019
Q3
$315K Buy
+4,113
New +$360K 0.01% 911

Other funds holding RGEN

HRT Financial's RGEN Position: Q2 2025 in Review

HRT Financial sold out of Repligen (RGEN) in Q2 2025, closing a stake of 9,004 shares — an estimated $1.15M sold.

HRT Financial first reported a position in RGEN in Q3 2019 and held it in 11 quarters. The position peaked at $18.2M in Q3 2021. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • HRT Financial reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 9,004 Repligen shares in Q2 2025, an estimated $1.15M.
  • HRT Financial first reported a position in Repligen in Q3 2019 and held it in 11 quarters.
  • HRT Financial's Repligen position peaked at $18.2M in Q3 2021.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.